{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T06:20:55Z","timestamp":1776579655540,"version":"3.51.2"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:00:00Z","timestamp":1603929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI055433"],"award-info":[{"award-number":["T32AI055433"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI125003"],"award-info":[{"award-number":["U01AI125003"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI138851"],"award-info":[{"award-number":["K23AI138851"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurologic Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS086312"],"award-info":[{"award-number":["R01NS086312"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K01TW010268"],"award-info":[{"award-number":["K01TW010268"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW009345"],"award-info":[{"award-number":["D43TW009345"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K01TW010268"],"award-info":[{"award-number":["K01TW010268"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K43TW010718"],"award-info":[{"award-number":["K43TW010718"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>C-reactive protein (CRP) is an acute phase protein produced by the liver in response to systemic inflammation. CRP is a helpful surrogate biomarker used for following the progression and resolution of infection. We aimed to determine the association of baseline CRP level and the temporal change in CRP over time with cryptococcal meningitis outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We reviewed 168 prospectively enrolled HIV-infected Ugandans with confirmed first-episode cryptococcal meningitis. Baseline plasma CRP collected within 5 days of meningitis diagnosis was categorized into quartiles. We compared baseline CRP with 18-week survival using time-to-event analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 168 participants, the baseline first quartile of serum CRP was &amp;lt;29.0 mg\/L, second quartile 29.0\u201349.5 mg\/L, third quartile 49.6\u201383.6 mg\/L, and fourth quartile &amp;gt;83.6 mg\/L. Baseline CD4 count, HIV viral load, and cerebrospinal fluid results did not differ by CRP quartile. Participants with CRP &amp;gt;49.5 mg\/L more likely presented with Glasgow Coma Scale (GCS) &amp;lt;15 (P\u2005=\u2005.03). The 18-week mortality rate was 55% (46\/84) in the highest 2 quartile CRP groups (&amp;gt;49.5 mg\/L), 41% (17\/42) in the mid-range CRP group (29.0\u201349.5 mg\/L), and 14% (6\/42) in the low-CRP group (&amp;lt;29.0 mg\/L; P\u2005&amp;lt;\u2005.001). After adjustment for possible confounding factors including GCS\u2005&amp;lt;15, CRP remained significantly associated with mortality (adjusted hazard ratio, 1.084 per 10 mg\/L; 95% CI, 1.031\u20131.139; P\u2005=\u2005.0016).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Higher baseline CRP is associated with increased mortality in HIV-infected individuals with first-episode cryptococcal meningitis. CRP could be a surrogate marker for undiagnosed coinfections or may reflect immune dysregulation, leading to worse outcomes in persons with advanced AIDS and concomitant cryptococcal meningitis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa530","type":"journal-article","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T14:00:56Z","timestamp":1603980056000},"source":"Crossref","is-referenced-by-count":9,"title":["Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3507-6411","authenticated-orcid":false,"given":"Supavit","family":"Chesdachai","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1118-4194","authenticated-orcid":false,"given":"Nicole W","family":"Engen","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0480-9646","authenticated-orcid":false,"given":"Joshua","family":"Rhein","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian","family":"Tugume","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadeo","family":"Kiiza Kandole","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Abassi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Ssebambulidde","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kasibante","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darlisha A","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-8876","authenticated-orcid":false,"given":"Caleb P","family":"Skipper","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2754-3473","authenticated-orcid":false,"given":"Kathy H","family":"Hullsiek","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdu K","family":"Musubire","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-0231","authenticated-orcid":false,"given":"Radha","family":"Rajasingham","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B","family":"Meya","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-0060","authenticated-orcid":false,"given":"David R","family":"Boulware","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,29]]},"reference":[{"key":"2020122901400013700_CIT0001","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020122901400013700_CIT0002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bjid.2012.10.020","article-title":"Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America","volume":"17","author":"Vidal","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"2020122901400013700_CIT0003","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/cid\/ciz488","article-title":"Cryptococcal antigen screening and preemptive treatment\u2014how can we improve survival","volume":"70","author":"Rajasingham","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020122901400013700_CIT0004","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-80-2-176","article-title":"Prognostic factors in cryptococcal meningitis. A study in 111 cases","volume":"80","author":"Diamond","year":"1974","journal-title":"Ann Intern Med"},{"key":"2020122901400013700_CIT0005","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"Kambugu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020122901400013700_CIT0006","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1258\/ijsa.2011.010538","article-title":"Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients","volume":"22","author":"Anekthananon","year":"2011","journal-title":"Int J STD AIDS"},{"key":"2020122901400013700_CIT0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1385\/IR:30:3:261","article-title":"C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity","volume":"30","author":"Du Clos","year":"2004","journal-title":"Immunol Res"},{"key":"2020122901400013700_CIT0008","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front Immunol"},{"key":"2020122901400013700_CIT0009","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcrc.2017.07.021","article-title":"Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer","volume":"42","author":"Rabello","year":"2017","journal-title":"J Crit Care"},{"key":"2020122901400013700_CIT0010","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc10313","article-title":"C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study","volume":"15","author":"P\u00f3voa","year":"2011","journal-title":"Crit Care"},{"key":"2020122901400013700_CIT0011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-3476(81)80319-8","article-title":"C-reactive protein in spinal fluid of children with meningitis","volume":"99","author":"Corrall","year":"1981","journal-title":"J Pediatr"},{"key":"2020122901400013700_CIT0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.diagmicrobio.2014.03.029","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"80","author":"Lin","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020122901400013700_CIT0013","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc11291","article-title":"Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study","volume":"16","author":"Coelho","year":"2012","journal-title":"Crit Care"},{"key":"2020122901400013700_CIT0014","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1007\/s00520-013-1844-1","article-title":"Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients","volume":"21","author":"Markov\u00e1","year":"2013","journal-title":"Support Care Cancer"},{"key":"2020122901400013700_CIT0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0163-4453(84)93883-0","article-title":"C-reactive protein response induced by fungal infections","volume":"8","author":"Kostiala","year":"1984","journal-title":"J Infect"},{"key":"2020122901400013700_CIT0016","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF01647219","article-title":"Serial study of C-reactive protein during fungal esophagitis and enterocolitis","volume":"15","author":"Kostiala","year":"1987","journal-title":"Infection"},{"key":"2020122901400013700_CIT0017","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2020122901400013700_CIT0018","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/infdis\/jiv067","article-title":"Early ART after cryptococcal meningitis is associated with cerebrospinal fluid pleocytosis and macrophage activation in a multisite randomized trial","volume":"212","author":"Scriven","year":"2015","journal-title":"J Infect Dis"},{"key":"2020122901400013700_CIT0019","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/QAD.0000000000000200","article-title":"Compartmentalization of innate immune responses in the central nervous system during cryptococcal meningitis\/HIV coinfection","volume":"28","author":"Naranbhai","year":"2014","journal-title":"AIDS"},{"key":"2020122901400013700_CIT0020","doi-asserted-by":"crossref","first-page":"e0120297","DOI":"10.1371\/journal.pone.0120297","article-title":"Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis","volume":"10","author":"Mora","year":"2015","journal-title":"PLoS One"},{"key":"2020122901400013700_CIT0021","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.174.3.1746","article-title":"IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis","volume":"174","author":"Siddiqui","year":"2005","journal-title":"J Immunol"},{"key":"2020122901400013700_CIT0022","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/infdis\/jit099","article-title":"The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis","volume":"207","author":"Jarvis","year":"2013","journal-title":"J Infect Dis"},{"key":"2020122901400013700_CIT0023","first-page":"24","article-title":"TH1\/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy","volume":"69","author":"Osakwe","year":"2010","journal-title":"Roum Arch Microbiol Immunol"},{"key":"2020122901400013700_CIT0024","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4049\/jimmunol.174.2.1027","article-title":"Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis","volume":"174","author":"Hernandez","year":"2005","journal-title":"J Immunol"},{"key":"2020122901400013700_CIT0025","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1469-0691.2005.01074.x","article-title":"Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis","volume":"11","author":"Lortholary","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"2020122901400013700_CIT0026","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.4049\/jimmunol.178.9.5753","article-title":"Protection from direct cerebral Cryptococcus infection by interferon-gamma-dependent activation of microglial cells","volume":"178","author":"Zhou","year":"2007","journal-title":"J Immunol"},{"key":"2020122901400013700_CIT0027","article-title":"Diagnosis and management of central nervous system cryptococcal infections in HIV-infected adults","volume":"5:65","author":"Skipper","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2020122901400013700_CIT0028","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"2020122901400013700_CIT0029","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10096-017-3142-1","article-title":"Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) Cryptococcal Meningitis Study","volume":"37","author":"Hakyemez","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020122901400013700_CIT0030","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/cid\/ciz485","article-title":"Cryptococcal-related mortality despite fluconazole preemptive treatment in a cryptococcal Antigen screen-and-treat program","volume":"70","author":"Wake","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020122901400013700_CIT0031","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1038\/s41598-019-43941-w","article-title":"Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study","volume":"9","author":"Hurtado","year":"2019","journal-title":"Sci Rep"},{"key":"2020122901400013700_CIT0032","doi-asserted-by":"crossref","first-page":"ofy122","DOI":"10.1093\/ofid\/ofy122","article-title":"Detrimental outcomes of unmasking cryptococcal meningitis with recent ART initiation","volume":"5","author":"Rhein","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020122901400013700_CIT0033","doi-asserted-by":"crossref","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","article-title":"Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study","volume":"7","author":"Boulware","year":"2010","journal-title":"PLoS Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa530\/34053298\/ofaa530.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/12\/ofaa530\/35224859\/ofaa530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/12\/ofaa530\/35224859\/ofaa530.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T06:40:26Z","timestamp":1609224026000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa530\/5942954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,29]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa530","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,10,29]]},"article-number":"ofaa530"}}